Islet Management’s AstraZeneca AZN Stock Holding History

Islet Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-123,644	Closed	-$10M	–	88
2019 Q1	$10M	Buy	+123,644	New	+$9.75M	1.16%	24

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Islet Management's AZN Position: Q2 2019 in Review

Islet Management sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 123,644 shares — an estimated $10M sold.

Islet Management first reported a position in AZN in Q1 2019 and held it in 1 quarter. The position peaked at $10M in Q1 2019. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

Islet Management reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
Islet Management sold 123,644 AstraZeneca shares in Q2 2019, an estimated $10M.
Islet Management first reported a position in AstraZeneca in Q1 2019 and held it in 1 quarter.
Islet Management's AstraZeneca position peaked at $10M in Q1 2019.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Islet Management's 13F filing for Q2 2019, filed 14 Aug 2019.